Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy

British Journal of Haematology

Volumn 94, Issue 1, 1996, Pages 112-115

  Hebbar, M ^a   Kaplan, C ^b   Caulier, M T ^a   Wattel, E ^a   Morel, P ^c   Wetterwald, M ^c   Bauters, F ^a   Fenaux, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Inst Natl de Transfusion Sananine   (France)

^c CH Lens ^*  (France)

Author keywords

Antiplatelet antibodies; MAIPA assay; MDS; Platelet lifespan; Thrombocytopenia

Indexed keywords

AUTOANTIBODY; DANAZOL; THROMBOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE LIFESPAN; THROMBOCYTOPENIA;

EID: 0030016064     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.6322262.x     Document Type: Article

References (12)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, N.R. & Sultan, C. (1982) The French-American-British (FAB) Cooperative Group: Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
2. Catalano, L., Selleri, C., Montuori, N., Fratellanza, G., Notaro, R., Fontana, R., Formisano, S. & Rotoli, B. (1993) Danazol for myelodysplastic syndromes. British Journal of Haematology, 85, 230-231.
3. Chabannon, C., Molina, L., Pégourié-Bandelier, B., Bost, M., Léger, J. & Hollard, D. (1994) A review of 76 patients with myelodysplastic syndromes treated with danazol. Cancer, 73, 3073-3080.
4. Fenaux, P., Caulier, M.T., Hirchauer, M.C., Beuscart, R., Goude-mand, J. & Bauters, F. (1989) Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases. European Journal of Haematology, 42, 259-264.
5. Kiefel, V., Santoso, S., Weisheit, M. & Müller-Eckhardt, C. (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood, 70, 1722-1726.
6. McMillan, R., Tani, P. & Millard, F. (1987) Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood, 70, 1040-1045.
7. Morel, P., Hebbar, M., Lai, J.L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F. & Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia, 7, 1315-1523.
8. Morel-Kopp, M.C. & Kaplan, C. (1994) Modification of the MAIPA technique to detect and identify anti-platelet glycoprotein autoantibodies. Platelets, 5, 285.
9. Morel-Kopp, M.C., Tchernia, G., Lambert, T., Verdy, E., Schleger, N., Dreyfus, M., Chateauvieux, L. & Kaplan, C. (1992) Autoantibodies directed against the platelet GP complex Ib-IX in normal individuals. Blood, 80, (Suppl. 1), abstract 187.
10. Saleh, M.N., Ferguson, S., Dumais, D.A., Knight, D.R. & Prchal, J.T. (1993) Myelodysplastic syndrome associated with immune thrombocytopenia. Blood, 82, (Suppl. 1), abstract 1515.
11. Stadtmauer, E., Cassileh, P., Edelstein, M., Abrahm, J., Schreiber, A., Nowell, R. & Douglas, B. (1991) Danazol treatment of myelodysplastic syndromes. British Journal of Haematology, 77, 502-508.
12. Wattel, E., Cambier, N., Caulier, M.T., Sautière, D., Bauters, F. & Fenaux, P. (1994) Androgen therapy in myelodysplastic syndromes (MDS) with severe thrombocytopenia: a report on 20 cases. British Journal of Haematology, 87, 205-208.